Basser Director of Gynecologic Research, Ronny Drapkin, MD, PhD, discusses the cellular origins of ovarian cancer in the fallopian tubes.

Basser Director of Gynecologic Cancer Research, Ronny Drapkin, MD, PhD, discusses the relationship between ovarian cancer and the fallopian tubes and highlights the importance of BRCA-related cancer research.

The Basser Center’s virtual Breakthroughs and Discoveries panel brought together internationally renowned experts in the field of BRCA-related cancer research and care to discuss how discoveries in the lab translate to patient care.

In this ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses recent advancements in treatment options for BRCA-related cancers, such as drugs like PARP inhibitors.

Basser Executive Director Susan Domchek, MD, discusses PARP inhibitors and ways in which they might be combined with other cancer treatments.

2016 Basser Global Prize winner, cancer geneticist Steven Narod, MD, FRCPC, PhD (hon), FRSC, director of the Familial Breast Cancer Research Unit and a senior scientist at the Women’s College Hospital in Toronto, Ontario, Canada, discusses BRCA-related cancer research.

The Sixth Annual Basser Center Scientific Symposium on Tuesday, May 22, and Wednesday, May 23, featured Keynote speaker and Basser Global Prize awardee Professor Ashok Venkitaraman, MBSS, PhD, from the University of Cambridge.

Ronny Drapkin, MD, PhD, Basser’s Director of Gynecologic Cancer Research, and Penn’s Ovarian Cancer Research Center shares the latest on early detection research for ovarian cancer.

The BFOR study provides genetic testing for common BRCA mutations for women and men of Ashkenazi (Eastern European) Jewish ancestry, age 25 or older, in four U.S. metropolitan areas.

The Seventh Annual Basser Center Scientific Symposium held on Tuesday, May 7, and Wednesday, May 8, featured Keynote speaker and Basser Global Prize awardee Maria Jasin, PhD, from Memorial Sloan Kettering Cancer Center.